Gene-Editing Trial in China Sparks Ethical Concerns After Child's Death
A gene-editing trial in China has come under scrutiny following the death of a child participant, raising significant ethical questions about the country's biotech practices. The trial, conducted at Xinhua Hospital in Shanghai, involved a six-year-old girl with a genetic defect. Her death, attributed to a severe immune reaction, was reportedly concealed by the researchers involved. This incident has sparked outrage and renewed debate over the ethical standards governing biotechnology in China, a country that has been striving to establish itself as a leader in the field. 
